Recombinant IGF1R (Cixutumumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IGF1R (Cixutumumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IGF1R (Cixutumumab Biosimilar) in samples from Human.
Catalog No. ABIN7487917
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IGF1R (Cixutumumab Biosimilar) antibody (ABIN7487917)
Target
IGF1R (Cixutumumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IGF1R (Cixutumumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Cixutumumab Biosimilar - Anti-IGF1R, CD221 mAb
-
Characteristics
- Antibody Type: IgG1-lambda
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 lambda
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IGF1R (Cixutumumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
IMC-A12,LY3012217
Cixutumumab (IMC-A12) is a fully human IgG1 monoclonal antibody directed against the human insulin-like growth factor-1 receptor (IGF-1R) with potential antineoplastic activity for the treatment of solid tumors. -
CAS-No
- 947687-12-9
Target
-
You are here:
